Olivier Danos Insider Trading $RGNX REGENXBIO Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Olivier Danos.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Olivier Danos. Olivier Danos is Chief Scientific Officer in REGENXBIO Inc. ($RGNX).
Olivier Danos in REGENXBIO Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Olivier Danos: Chief Scientific Officer
Holdings: 6,802 shares
Current Value: $116,654
Latest Transaction: Jan 06 2021
$RGNX Market Capitalization: $465.96M
$RGNX Previous Close: $17.15
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Olivier Danos in REGENXBIO Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 06 2021 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Option Exercise | A | 44.97 | 52,500 | 2,360,925 | 52,500 | |
| Jan 06 2021 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Grant | A | 0.00 | 11,600 | 0 | 19,043 | 7.4 K to 19 K (+155.85 %) |
| Jan 06 2021 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Grant | A | 31.31 | 641 | 20,067 | 7,443 | 6.8 K to 7.4 K (+9.42 %) |
| Jan 06 2021 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Grant | A | 34.82 | 302 | 10,517 | 6,802 | 6.5 K to 6.8 K (+4.65 %) |
| Jan 06 2020 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Option Exercise | A | 38.99 | 48,000 | 1,871,520 | 48,000 | |
| Apr 17 2019 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Option Exercise | M | 20.35 | 2,000 | 40,700 | 71,500 | |
| Apr 17 2019 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Sell | S | 53.09 | 1,000 | 53,090 | 6,500 | 7.5 K to 6.5 K (-13.33 %) |
| Apr 17 2019 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Sell | S | 52.23 | 1,000 | 52,230 | 7,500 | 8.5 K to 7.5 K (-11.76 %) |
| Apr 17 2019 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Buy | M | 20.35 | 2,000 | 40,700 | 8,500 | 6.5 K to 8.5 K (+30.77 %) |
| Mar 14 2019 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Option Exercise | M | 20.35 | 5,000 | 101,750 | 73,500 | |
| Mar 14 2019 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Buy | M | 20.35 | 5,000 | 101,750 | 6,500 | 1.5 K to 6.5 K (+333.33 %) |
| Jan 07 2019 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Option Exercise | A | 40.82 | 48,000 | 1,959,360 | 48,000 | |
| Dec 04 2018 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Option Exercise | M | 20.35 | 1,500 | 30,525 | 78,500 | |
| Dec 04 2018 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Buy | M | 20.35 | 1,500 | 30,525 | 1,500 | 0 to 1.5 K |
| Oct 10 2018 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Option Exercise | M | 20.35 | 20,000 | 407,000 | 80,000 | |
| Oct 10 2018 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Sell | S | 65.60 | 216 | 14,170 | 0 | 216 to 0 (-100.00 %) |
| Oct 10 2018 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Sell | S | 64.78 | 4,000 | 259,120 | 216 | 4.2 K to 216 (-94.88 %) |
| Oct 10 2018 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Sell | S | 63.73 | 12,284 | 782,859 | 4,216 | 16.5 K to 4.2 K (-74.45 %) |
| Oct 10 2018 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Sell | S | 62.79 | 3,500 | 219,765 | 16,500 | 20 K to 16.5 K (-17.50 %) |
| Oct 10 2018 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Buy | M | 20.35 | 20,000 | 407,000 | 20,000 | 0 to 20 K |
| Jan 05 2018 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Option Exercise | A | 35.80 | 41,250 | 1,476,750 | 41,250 | |
| Mar 29 2017 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Option Exercise | A | 20.35 | 100,000 | 2,035,000 | 100,000 |
Page: 1